Nuvasive Stock Fundamentals
| NUVADelisted Stock | USD 42.35 0.85 1.97% |
NuVasive fundamentals help investors to digest information that contributes to NuVasive's financial success or failures. It also enables traders to predict the movement of NuVasive Stock. The fundamental analysis module provides a way to measure NuVasive's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NuVasive stock.
NuVasive |
NuVasive Company Return On Equity Analysis
NuVasive's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current NuVasive Return On Equity | 0.0331 |
Most of NuVasive's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NuVasive is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, NuVasive has a Return On Equity of 0.0331. This is 100.14% lower than that of the Health Care Equipment & Supplies sector and 100.38% lower than that of the Health Care industry. The return on equity for all United States stocks is 110.68% lower than that of the firm.
NuVasive Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NuVasive's current stock value. Our valuation model uses many indicators to compare NuVasive value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NuVasive competition to find correlations between indicators driving NuVasive's intrinsic value. More Info.NuVasive is regarded fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.73 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for NuVasive is roughly 1.37 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NuVasive's earnings, one of the primary drivers of an investment's value.NuVasive Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NuVasive's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NuVasive could also be used in its relative valuation, which is a method of valuing NuVasive by comparing valuation metrics of similar companies.NuVasive is currently under evaluation in return on equity category among its peers.
NuVasive Fundamentals
| Return On Equity | 0.0331 | |||
| Return On Asset | 0.0242 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 2.91 B | |||
| Shares Outstanding | 52.45 M | |||
| Shares Owned By Insiders | 0.27 % | |||
| Shares Owned By Institutions | 99.73 % | |||
| Number Of Shares Shorted | 5.76 M | |||
| Price To Earning | 51.79 X | |||
| Price To Book | 2.62 X | |||
| Price To Sales | 1.79 X | |||
| Revenue | 1.2 B | |||
| Gross Profit | 865.43 M | |||
| EBITDA | 211.8 M | |||
| Net Income | 40.41 M | |||
| Cash And Equivalents | 225.98 M | |||
| Cash Per Share | 4.34 X | |||
| Total Debt | 1.01 B | |||
| Debt To Equity | 1.22 % | |||
| Current Ratio | 1.17 X | |||
| Book Value Per Share | 17.02 X | |||
| Cash Flow From Operations | 169.12 M | |||
| Short Ratio | 10.29 X | |||
| Earnings Per Share | 0.53 X | |||
| Price To Earnings To Growth | 4.83 X | |||
| Target Price | 44.0 | |||
| Number Of Employees | 3 K | |||
| Beta | 1.07 | |||
| Market Capitalization | 2.08 B | |||
| Total Asset | 2.22 B | |||
| Retained Earnings | 86.11 M | |||
| Working Capital | 149.16 M | |||
| Current Asset | 702.83 M | |||
| Current Liabilities | 99.62 M | |||
| Z Score | 2.23 | |||
| Net Asset | 2.22 B |
About NuVasive Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NuVasive's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NuVasive using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NuVasive based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California. Nuvasive operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2900 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in NuVasive Stock
If you are still planning to invest in NuVasive check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NuVasive's history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |